An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret

British Journal of Pharmacology

Volumn 118, Issue 2, 1996, Pages 209-214

  Rudd, J A ^b   Naylor, R J ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Acute and delayed; Cisplatin; Dexamethasone; Emesis; Ferret model; Ondansetron

Indexed keywords

CISPLATIN; DEXAMETHASONE; ONDANSETRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; FERRET; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; VOMITING;

EID: 0029944390     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15388.x     Document Type: Article

References (26)

1. AAPRO, M.S. (1992). Pharmacological treatment of delayed emesis. In Mechanisms and Control of Emesis. ed. Bianchi A.L., Grélot, L., Miller, A.D. & King, G.L. pp. 141-146. Paris: Inserm: John Libbey Eurotext.
2. ANDREWS, P.L.R., RAPEPORT, W.G. & SANGER, G.J. (1988). Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol. Sci., 9, 334-341.
3. BAXENDALE, B.R , VATER, M. & LAVER, K.M. (1993). Dexamethasone reduces pain and swelling following extraction of third molar teeth. Anaesthesia, 48, 961-964.
4. 3 receptor antagonist BRL 43694. Br. J. Cancer, 58, 644-650.
5. BISHOP, J.F., MATTHEWS, J.P., WOLF, M.M., OLIVER, I.N., REYNOLDS, S., WALPOLE, E., RISCHIN, D., BUCHANAN, L. & TAN, L.G. (1992). A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy. Eur. J. Cancer, 28, 47-50.
6. CERSOSIMO, R.J. & KARP, D.D. (1986). Adrenal corticosteroids as antiemetics during cancer chemotherapy. Pharmacotherapy, 6, 118-127.
7. CHEVALLIER, B., MARTY, M., PAILLARSE, J.-M. (1994). Methylprednisolone enhances the efficacy of ondansetron in acute and delayed emesis over at least three cycles. Ondansetron study group. Br. J. Cancer, 70, 1171-1175.
8. FREDRIKSON, M., HURSTI, T., FÜRST, C.J., STEINECK, G., BÖRJESON, S., WIKBLOM, M. & PETERSON, C. (1992). Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. Br. J. Cancer, 65, 779-780.
9. GANDARA, D.R., HARVEY, W.H., MONAGHAN, G.G., PEREZ, E.A. & HESKETH, P.J. (1993). Delayed emesis following high-dose cisplatin-a double-blind randomised comparative trial of ondansetron (GR-38032F) versus placebo. Eur. J. Cancer, 29A, S35-S38.
10. 3 receptor antagonist on cyclophosphamide induced vomiting in the ferret. Br. J. Cancer, 61, 56-60.
11. 3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br. J. Pharmacol., 97, 247-255.
12. HIRSTI, T.J., FREDRIKSON, M., STEINECK, G., BÖRJESON, S., FÜRST, C.J. & PETERSON, C. (1993). Endogenous cortisol exerts anti-emetic effect similar to that of exogenous corticosteroids. Br. J. Cancer, 68, 112-114.
13. KRIS, M.G., TYSON, L.B., CLARK, R.A. & GRALLA, R.J. (1992). Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase-II study and a review of completed trials to manage delayed emesis. Cancer, 70, 1012-1016.
14. MARR, H.E., DAVEY, P.D. & BLOWER, P. (1992). The effect of dexamethasone alone or in combination with granisetron, on cisplatin-induced emesis in the ferret. Br. J. Pharmacol., 104, 371P.
15. MATARUSKI, M.R., KEIS, N.A., SMOUSE, D.J. & WORKMAN, M.L. (1990). Effects of steroids on postoperative nausea and vomiting. Nurse Anesthesia, 1, 183-188.
16. NAYLOR, R.J. & RUDD, J.A. (1994). Emesis and anti-emesis. In Cancer Surveys, Advances and Prospects in Clinical, Epidemiological and Laboratory Oncology, ed. Sidesbottom, E. & Franks, L.M. pp. 177-194. New York: Cold Spring Harbour Laboratory Press.
17. RATH, U., UPADHYAYA, B.K., ARECHAVALA, E., BOCKMANN, H., DEARNALEY, D., DROZ, J.P., FOSSA, S.D., HENRIKSSON, R., AULITZKY, W.E., JONES, W.G., WEISSBACH, L., PASKA, W. & FREEMAN, A. (1993). Role of ondansetron plus dexamethasone in fractionated chemotherapy. Oncology, 50, 168-172.
18. RIDGEWAY, C.K., BROPHY, T.R., YELLAND, J.D.N. & EADIE, M.J. (1984). Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J. Neurol. Neurosurg. Psychiat., 47, 1087-1090.
19. ROILA, F. (1993). Ondansetron plus dexamethasone compared to the standard metoclopramide combination. Oncology, 50, 163-167.
20. RUDD, J.A., BUNCE, K.T., & NAYLOR, R.J. (1995). The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret. Neuropharmacol., 35, 91-97.
21. RUDD, J.A., JORDAN, C.C. & NAYLOR, R.J. (1994). Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis. Eur. J. Pharmacol., 262, R1-R2.
22. 3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret. Neuropharmacol., 33, 1607-1608.
23. RUFF, P., PASKA, W., GOEDHALS, L., POUILLART, P., RIVIERE, A., VOROBIOF, D., BLOCH, B., JONES, A., MARTIN, C., BRUNET, R., BUTCHER, M., FORSTER, J. & MCQUADE, B. (1994). Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis - a multicentre double-blind, randomised, parallel-group study. Oncology, 51, 113-118.
24. SANGER, G.S. (1993). The pharmacology of antiemetic agents. In Emesis in Anti-cancer Therapy. ed. Andrews, P.L.R. & Sanger, G.J. pp. 179-210. London: Chapman & Hall Medical.
25. SMITH, D.B., NEWLANDS, E.S., RUSTIN, G.J.S., BEGENT, R.H.J., HOWELLS, N., MCQUADE, B. & BAGSHAWE, K.D. (1991). Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet, 338, 487-490.
26. TSUEI, S.E., MOORE, R.G., ASHLEY, J.J. & MCBRIDE, W.G. (1979). Disposition of synthetic glucocorticoids. 1. Pharmacokinetics of dexamethasone in healthy adults. J. Pharmaco. Biopharm., 7, 249-264.